IM Cannabis Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

IM Cannabis's earnings have been declining at an average annual rate of -13.2%, while the Pharmaceuticals industry saw earnings growing at 46% annually. Revenues have been growing at an average rate of 34.7% per year.

Anahtar bilgiler

-13.2%

Kazanç büyüme oranı

6.7%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi23.1%
Gelir büyüme oranı34.7%
Özkaynak getirisi-276.1%
Net Marj-28.2%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Slammed 28% IM Cannabis Corp. (CSE:IMCC) Screens Well Here But There Might Be A Catch

Sep 13
Slammed 28% IM Cannabis Corp. (CSE:IMCC) Screens Well Here But There Might Be A Catch

A Piece Of The Puzzle Missing From IM Cannabis Corp.'s (CSE:IMCC) Share Price

Jul 30
A Piece Of The Puzzle Missing From IM Cannabis Corp.'s (CSE:IMCC) Share Price

Potential Upside For IM Cannabis Corp. (CSE:IMCC) Not Without Risk

Jul 19
Potential Upside For IM Cannabis Corp. (CSE:IMCC) Not Without Risk

Health Check: How Prudently Does IM Cannabis (CSE:IMCC) Use Debt?

Dec 24
Health Check: How Prudently Does IM Cannabis (CSE:IMCC) Use Debt?

Don't Ignore The Fact That This Insider Just Sold Some Shares In IM Cannabis Corp. (CSE:IMCC)

Feb 05
Don't Ignore The Fact That This Insider Just Sold Some Shares In IM Cannabis Corp. (CSE:IMCC)

What Percentage Of IM Cannabis Corp. (CSE:IMCC) Shares Do Insiders Own?

Jan 08
What Percentage Of IM Cannabis Corp. (CSE:IMCC) Shares Do Insiders Own?

Gelir ve Gider Dağılımı

IM Cannabis nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

CNSX:IMCC Gelir, gider ve kazançlar (CAD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 2450-14190
31 Mar 2448-15200
31 Dec 2349-9220
30 Sep 2353-15180
30 Jun 2354-17210
31 Mar 2354-17230
31 Dec 2254-23240
30 Sep 2250-22320
30 Jun 2244-16320
31 Mar 2238-10300
31 Dec 21340290
30 Sep 2129-10270
30 Jun 2127-12230
31 Mar 2123-24230
31 Dec 2016-29190
30 Sep 2013-7140
30 Jun 2010-10130
31 Mar 208-1110
31 Dec 199-7100
30 Sep 198-890
30 Jun 197-670
31 Mar 196-650
31 Dec 185230
31 Dec 174120

Kaliteli Kazançlar: IMCC is currently unprofitable.

Büyüyen Kar Marjı: IMCC is currently unprofitable.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: IMCC is unprofitable, and losses have increased over the past 5 years at a rate of 13.2% per year.

Büyüme Hızlandırma: Unable to compare IMCC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Kazançlar vs. Sektör: IMCC is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-40.8%).


Özkaynak Getirisi

Yüksek ROE: IMCC has a negative Return on Equity (-276.08%), as it is currently unprofitable.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin